Clayton A Smith

7PUBLICATIONS
52CO-AUTHORS
Planning and decision makingHaematological tumoursGene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 02, 2025
Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine.

Nazmul Islam, Justin L Dale, Jamie S Reuben

|Aug 21, 2024
Predictive Models for Long Term Survival of AML Patients Treated with Venetoclax and Azacitidine or 7+3 Based on Post Treatment Events and Responses: Retrospective Cohort Study.

Nazmul Islam, Jamie S Reuben, Justin Dale

|May 24, 2024
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium.

Anagha Inguva Sheth, Mark J Althoff, Hunter Tolison

|Jun 26, 2023
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.

Shanshan Pei, Ian T Shelton, Austin E Gillen

|Oct 04, 2022
Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.

Nazmul Islam, Jamie S Reuben, Justin Dale

|Oct 28, 2020
Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy.

Zachary J Walker, Beau M Idler, Lorraine N Davis

Pageof 2

Frequent Collaborators

7 joint publications

Craig T Jordan

3 joint publications

Jamie S Reuben

3 joint publications

Krysta Engel

3 joint publications

Amanda Winters